| Identification | Back Directory | [Name]
N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(3-pyridinyl)ethynyl]benzamide | [CAS]
1240489-67-1 | [Synonyms]
N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(3-pyridinyl)ethynyl]benzamide | [Molecular Formula]
C29H29F3N4O | [MOL File]
1240489-67-1.mol | [Molecular Weight]
506.56 |
| Hazard Information | Back Directory | [Uses]
XMD15-44 is a RET kinase inhibitor.XMD15-44 has a growth-inhibitory effect on RET/C634R and RET/M918T transformed RAT1 cells, with IC50 values of 11.5 nM and 8.3 nM, respectively. XMD15-44 can inhibit RET kinase and signaling in human thyroid cancer cell lines carrying oncogenic RET alleles, reducing cell proliferation[1]. | [References]
[1] Moccia M, et al. Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase. PLoS One. 2015 Jun 5;10(6):e0128364. DOI:10.1371/journal.pone.0128364 |
|
|